---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-132303"
form_type: "8-K"
ticker: "ALKS"
cik: "0001520262"
company_name: "Alkermes plc."
filed_at: "2024-12-02T23:59:59+00:00"
generated_at: "2026-05-29T11:17:40.391562+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Alkermes releases updated corporate presentation; no new financial data

## Summary
- December 2, 2024: Alkermes made available an updated corporate presentation.
- Presentation titled 'Alkermes 2024: Profitable, Pure-play Neuroscience Company'.
- No new financial guidance, pipeline updates, or product launches were disclosed.

## SEC filing metadata
- accession: 0000950170-24-132303
- form_type: 8-K
- ticker: ALKS
- cik: 0001520262
- company_name: Alkermes plc.
- filed_at: 2024-12-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1520262/000095017024132303/0000950170-24-132303-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1520262/000095017024132303/alks-20241202.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-132303
- JSON: https://secwatch.observer/filing/0000950170-24-132303.json
- Plain text: https://secwatch.observer/filing/0000950170-24-132303.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.